Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Monthly Archives: May 2010
CANCELLATION OF WARF STEM CELL CLAIMS: THE “DR. HYDE” SIDE OF KSR
Recently, in a notably unremarked decision, the Board reversed the Examiner, effectively canceling all of the claims to pluripotent human embryonic stem cells (ES) in Thomson (U.S. Pat. No. 7029913): The Foundation for Taxpayer & Consumer Rights v. Patent of Wisconsin Alumni … Continue reading
Posted in Obviousness
Tagged biotechnology law, Federal Circuit, intellectual property, Warren Woessner
Leave a comment
Chisum On Patents – Live in Seattle!
The Chisum Patent Academy will offer its second annual Intensive Patent Law Training Workshop at its offices in Seattle, Washington, on July 29-31, 2010. See https://www.chisum-patent-academy.com/. The workshop will focus on substantive patent law (patentability and enforcement) through analysis of critical … Continue reading
A “Myriad” Of Questions To Resolve? Back To The Basics Of 101
Thinking about Judge Sweet’s recent decision in Ass’n of Molecular Pathologists v. USPTO et al. (The “Myriad Decision”), I am again struck by the wide path the good judge slashed through the field (or is it the jungle now) of … Continue reading
Director Kappos Comments on Ariad v. Lilly
USPTO David Kappos recently posted a comment on the Fed. Cir. decision in Ariad v. Lilly in which he noted that the Fed. Cir. held that broad functional claims (presumably mechanism-of-action claims) must be supported by sufficient species (read “working examples”). While … Continue reading
Posted in Written Description Requirements (WDR)
Tagged Ariad v. Lilly, David Kappos, Patent Law, patents, USPTO, Warren Woessner
Leave a comment